Labiotech.eu

News and Trends 11 Dec 2018

What Does the Largest Biotech IPO Ever Mean for European Biotech?

With a massive €530M ($604M) raised, US-based Moderna has made a record biotech IPO. The news could give a significant boost to developers of messenger RNA, a technology that is still several years away from the market. Entering the Nasdaq with a €7B ($8B) market cap, Moderna made history last Friday with a technology that […]

December 11, 2018 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 11 Dec 2018

Robotic Organoid Platform to Boost Personalized Medicine

The Swiss biotech Sun Bioscience has launched a robotic platform designed to standardize the production of 3D cell models of organs called organoids, making it easier to personalize treatments to a patient. Organoids are clusters of cells grown in the lab, and developed into miniature organs, such as the brain or intestine. Often no bigger […]

December 11, 2018 - 3 minutesmins - By Jonathan Smith

alnylam silence therapeutics lawsuit settlement

News and Trends 11 Dec 2018

UK Biotech Settles Lawsuit on the First RNAi Drug

Silence Therapeutics and Alnylam have reached a settlement that puts an end to a legal dispute between them resulting in Silence receiving some royalties on Onpattro, the first RNA interference drug. The lawsuit started last year, when Silence went to the UK courts claiming that Alnylam was infringing on its intellectual property. As part of […]

December 11, 2018 - 3 minutesmins - By Clara Rodríguez Fernández

In Depth 11 Dec 2018

Easy as ATCG: Commercialization of DNA as Data Storage

You could be storing information in DNA sooner than you might think. Although the technology is still quite early — the first video encoded in DNA, revealed last year, was quite simple — the rate at which the cost of writing DNA is going down might make DNA data storage a reality in the coming […]

December 11, 2018 - 5 minutesmins - By External Contributor

News and Trends 10 Dec 2018

Scientists Repurpose Skin Cells to Fight Cancer

Researchers have reprogrammed skin cells to make them behave like immune cell sentinels called dendritic cells, which can recruit the immune system to fight tumors. This discovery makes a step toward better cancer immunotherapy. “We are merging two different areas of research,” Carlos-Filipe Pereira, from Lund University, Sweden, said to me. “One of them is […]

December 10, 2018 - 3 minutesmins - By Jonathan Smith

genomics machine learning personalized medicine

More News! 10 Dec 2018

British Company Raises €37M to Personalize Therapies with Machine Learning

Genomics, a company based in Oxford, has increased the amount raised in a Series B round that will fund further development of its genomics technology for personalized medicine. The company adds a further €9M (£8M) to the round with the participation of Foresite Capital and F-Prime Capital, two renowned US life sciences investors. The previous […]

December 10, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 7 Dec 2018

Orchard’s Gene Therapy for Rare Immune Disease Works for Over a Year

A single dose of a gene therapy developed by Orchard Therapeutics can restore immune function for at least a year in patients with X-linked chronic granulomatous disease (X-CGD). The gene therapy was trialed in patients between the ages of 2 and 27 with the rare disease, which is caused by a rare genetic mutation that […]

December 7, 2018 - 3 minutesmins - By Clara Rodríguez Fernández

desentum hay fever allergy vaccine espoo

Startup Scout 7 Dec 2018

This Hypoallergenic Vaccine Could Alleviate Hay Fever Faster Than Approved Vaccines

We decided to make a visit to Espoo, Finland, this week, to visit Desentum. The company is developing allergy vaccines that could be safer and faster than approved vaccines. Mission: To make a vaccine that decreases the time taken to reduce allergies compared with approved vaccines, which contain the natural allergen. Desentum plans to do […]

December 7, 2018 - 4 minutesmins - By Jonathan Smith

News and Trends 6 Dec 2018

UK Project Hits 100,000 Genomes Target

In a step forward for the world of personalized medicine, the UK Government-backed 100,000 Genomes Project has reached its sequencing target. The project, which is one of the largest of its kind, was designed to collect genomic data to improve the capacity of personalized medicine, as well as learning more about the genetic basis of […]

December 6, 2018 - 2 minutesmins - By Helen Albert

News and Trends 6 Dec 2018

Update: Liver Gene Therapy 8 Times Stronger Than Usual

Update (06/12/2018): uniQure has incorporated Synpromics’ strong liver promoter into a preclinical gene therapy candidate for treating hemophilia A. Published on 08/10/2018 Synpromics and uniQure have unveiled new technology for precise genetic control that could make gene therapy safer and more precise. The team has developed a gene therapy system that is highly selective for […]

December 6, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

Inside Labiotech 6 Dec 2018

We Are Now More Than 150,000 Awesome Biotechers Every Month

Woohooo! We’ve hit 150,000 unique visitors per month to our site! What a beautiful number. We are so happy to be able to bring you great content every day and have our biotech network grow with more amazing people. Why this makes us so happy? Because it means that, 150,000 different people stopped by our website […]

December 6, 2018 - 2 minutesmins - By Editorial Team

argenx llama inspired antibodies cover cancer immunotherapy

News and Trends 5 Dec 2018

Llama-Inspired Antibodies Succeed in Clinical Trials and Financial Deal

Autoimmune disease and acute myeloid leukemia may have a llama-inspired antibody treatment one day. The Dutch company argenx’s antibodies have shown positive results in clinical trials, and have attracted Janssen into a collaboration to advance their use in cancer immunotherapy. In a phase II trial, the company’s lead antibody, efgartigimod, reduced the number of bleeding […]

December 5, 2018 - 3 minutesmins - By Jonathan Smith

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

What Does the Largest Biotech IPO Ever Mean for European Biotech?

Robotic Organoid Platform to Boost Personalized Medicine

UK Biotech Settles Lawsuit on the First RNAi Drug

Easy as ATCG: Commercialization of DNA as Data Storage

Scientists Repurpose Skin Cells to Fight Cancer

British Company Raises €37M to Personalize Therapies with Machine Learning

Orchard’s Gene Therapy for Rare Immune Disease Works for Over a Year

This Hypoallergenic Vaccine Could Alleviate Hay Fever Faster Than Approved Vaccines

UK Project Hits 100,000 Genomes Target

Update: Liver Gene Therapy 8 Times Stronger Than Usual

We Are Now More Than 150,000 Awesome Biotechers Every Month

Llama-Inspired Antibodies Succeed in Clinical Trials and Financial Deal

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!